Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.

Biotechnology

biomea fusion

Thomas Butler

Anthony Souza

Niki Low

Juan Pablo Frías

Caroline Perez-Dupont

Ravi Upasani

Hanna Cho

Steve Morris

Ramses Erdtmann

Thorsten Kirschberg

Franco Valle

Naomi Cretcher

Heow Tan

Scientific and Research

Clinical Operations

Directors and Senior Managers

Leadership Team

Accounting and Finance

Quality Assurance Team

Human Resources

Information Technology Team

Teams at biomea fusion